Published in J Virol on February 01, 1993
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J Virol (1994) 1.41
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J Virol (1994) 1.08
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol (2006) 1.08
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis. J Virol (1994) 1.01
The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions. J Virol (1999) 1.00
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol (1997) 0.97
Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1. J Virol (1999) 0.96
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (1995) 0.90
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol (2008) 0.89
Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus. J Virol (1998) 0.86
Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus. J Gen Virol (2014) 0.84
Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope. J Virol (1997) 0.84
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity. Clin Vaccine Immunol (2007) 0.81
Development of a Western blot assay for detection of bovine immunodeficiency-like virus using capsid and transmembrane envelope proteins expressed from recombinant baculovirus. Clin Diagn Lab Immunol (1999) 0.80
Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1. Clin Exp Immunol (1995) 0.80
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 8.68
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses (1989) 7.34
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci U S A (1989) 6.58
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Amino acid substitutions in structurally related proteins. A pattern recognition approach. Determination of a new and efficient scoring matrix. J Mol Biol (1988) 6.01
Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol (1990) 5.20
Antigenic diversity thresholds and the development of AIDS. Science (1991) 5.13
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (1992) 4.53
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res (1988) 3.89
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol (1991) 3.46
Comparison of two host cell range variants of feline immunodeficiency virus. J Virol (1990) 2.98
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci U S A (1986) 2.54
Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A (1989) 2.21
The emergence of simian/human immunodeficiency viruses. AIDS Res Hum Retroviruses (1992) 1.94
A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A (1992) 1.77
Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol (1989) 1.63
Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr (1990) 1.59
Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol (1990) 1.59
Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J Virol (1991) 1.52
Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol (1992) 1.41
Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J Virol (1991) 1.19
Identification of feline immunodeficiency virus rev gene activity. J Virol (1991) 1.18
Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes. EMBO J (1987) 1.18
Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J Virol (1992) 1.15
B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. J Gen Virol (1990) 1.15
Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res (1991) 1.06
Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol Immunol (1992) 1.03
Functional tolerance of the human immunodeficiency virus type 1 envelope signal peptide to mutations in the amino-terminal and hydrophobic regions. J Virol (1992) 0.96
Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts. AIDS (1988) 0.92
In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease. Vet Microbiol (1992) 0.86
Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1. J Acquir Immune Defic Syndr (1989) 0.85
Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses. AIDS Res Hum Retroviruses (1991) 0.77
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2000) 34.79
Cn3D: sequence and structure views for Entrez. Trends Biochem Sci (2000) 16.98
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nat Genet (2000) 14.51
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (1987) 7.96
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell (1985) 7.86
Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature (2001) 7.53
Genome sequence of the plant pathogen Ralstonia solanacearum. Nature (2002) 6.23
HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr (1989) 6.16
Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus. Cell (1986) 6.07
Genomic exploration of the hemiascomycetous yeasts: 1. A set of yeast species for molecular evolution studies. FEBS Lett (2000) 3.71
Sequences of the malE gene and of its product, the maltose-binding protein of Escherichia coli K12. J Biol Chem (1984) 3.10
Bacterial mode of replication with eukaryotic-like machinery in a hyperthermophilic archaeon. Science (2000) 2.64
The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J Virol (1989) 2.46
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob Agents Chemother (2004) 2.44
Genome sequence comparison and scenarios for gene rearrangements: a test case. Genomics (1995) 2.32
Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22
Palindromic units are part of a new bacterial interspersed mosaic element (BIME). Nucleic Acids Res (1991) 2.22
Genetic organization of gibbon ape leukemia virus. Virology (1989) 2.18
MMDB: Entrez's 3D structure database. Nucleic Acids Res (1999) 2.17
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Magnetic resonance imaging in antenatal diagnosis of tuberous sclerosis. Lancet (1992) 2.09
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J Virol (1993) 1.98
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol (1995) 1.77
Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci U S A (1984) 1.71
Comparison of sequences from the malB regions of Salmonella typhimurium and Enterobacter aerogenes with Escherichia coli K12: a potential new regulatory site in the interoperonic region. Mol Gen Genet (1989) 1.70
Genomic exploration of the hemiascomycetous yeasts: 18. Comparative analysis of chromosome maps and synteny with Saccharomyces cerevisiae. FEBS Lett (2000) 1.69
Characterization and repeat analysis of the compact genome of the freshwater pufferfish Tetraodon nigroviridis. Genome Res (2000) 1.57
Fetal lung volume: estimation at MR imaging-initial results. Radiology (2001) 1.52
Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. Virology (1990) 1.51
A primal sketch of the cortex mean curvature: a morphogenesis based approach to study the variability of the folding patterns. IEEE Trans Med Imaging (2003) 1.49
Nucleotide sequence and evolution of ETn elements. Proc Natl Acad Sci U S A (1987) 1.42
Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology (1993) 1.41
Versatility of a vector for expressing foreign polypeptides at the surface of gram-negative bacteria. Gene (1988) 1.34
The BIME family of bacterial highly repetitive sequences. Res Microbiol (1991) 1.31
Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D. J Virol (1998) 1.29
RNA polymerases B and C are more closely related to each other than to RNA polymerase A. J Biol Chem (1988) 1.27
Control of pilus expression in Neisseria gonorrhoeae as an original system in the family of two-component regulators. Mol Microbiol (1991) 1.24
Structural and functional diversity among bacterial interspersed mosaic elements (BIMEs). Mol Microbiol (1994) 1.22
Molar tooth sign and superior vermian dysplasia: a radiological, clinical, and genetic study. Neuropediatrics (2006) 1.21
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol (1999) 1.20
Molecular characterization of the resolvase gene, res, carried by a multicopy plasmid from Clostridium perfringens: common evolutionary origin for prokaryotic site-specific recombinases. Mol Microbiol (1987) 1.19
Erratic G-->A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. Virology (1995) 1.18
Genomic exploration of the hemiascomycetous yeasts: 20. Evolution of gene redundancy compared to Saccharomyces cerevisiae. FEBS Lett (2000) 1.18
Genomic exploration of the hemiascomycetous yeasts: 19. Ascomycetes-specific genes. FEBS Lett (2000) 1.16
Conserved framework of envelope glycoproteins among lentiviruses. Curr Top Microbiol Immunol (1994) 1.15
Multienzymatic non ribosomal peptide biosynthesis: identification of the functional domains catalysing peptide elongation and epimerisation. C R Acad Sci III (1995) 1.14
Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J Virol (1995) 1.11
The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo. Virology (1996) 1.11
Evidence in the mouse for self-renewing stem cells in the formation of a segmented longitudinal structure, the myotome. Development (1996) 1.09
Fetal lung volume measurement by magnetic resonance imaging in congenital diaphragmatic hernia. BJOG (2001) 1.06
Intracranial venous anomalies associated with atretic cephalocoeles. Pediatr Radiol (2000) 1.05
Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties. Virology (1995) 1.04
The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology (1995) 1.04
Species specificity of bacterial palindromic units. J Mol Evol (1987) 1.04
Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol Immunol (1992) 1.03
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
B-cell epitopes of the envelope glycoprotein of caprine arthritis-encephalitis virus and antibody response in infected goats. J Gen Virol (2000) 1.02
[Comparison of several protein sequences by recognition of conserved regions]. C R Acad Sci III (1986) 1.02
Progress in the identification of interaction sites on the periplasmic maltose binding protein from E coli. Biochimie (1991) 1.01
Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis. J Virol (1994) 1.01
Phenotypic suppression by incorporation of an alien amino acid. J Mol Biol (1993) 1.01
Genomic exploration of the hemiascomycetous yeasts: 21. Comparative functional classification of genes. FEBS Lett (2000) 0.99
A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol (1986) 0.99
Streptogramin B biosynthesis in Streptomyces pristinaespiralis and Streptomyces virginiae: molecular characterization of the last structural peptide synthetase gene. Antimicrob Agents Chemother (1997) 0.99
Prenatal prognosis of congenital diaphragmatic hernia using magnetic resonance imaging measurement of fetal lung volume. Ultrasound Obstet Gynecol (2005) 0.99
Value of prenatal magnetic resonance imaging in the prediction of postnatal outcome in fetuses with diaphragmatic hernia. Ultrasound Obstet Gynecol (2008) 0.98
Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Res Virol (1993) 0.97
A survey of polypeptide deformylase function throughout the eubacterial lineage. J Mol Biol (1997) 0.97
Hepatitis B virus DNA in Dane particles: evidence for the presence of replicative intermediates. J Infect Dis (1985) 0.97
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol (1997) 0.97
The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques. J Virol (2000) 0.96
Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1. J Virol (1999) 0.96
In the search of Mycoplasma genitalium lost substrate-binding proteins: sequence divergence could be the result of a broader substrate specificity. Mol Microbiol (1996) 0.96
Hidden mortality of prenatally diagnosed vein of Galen aneurysmal malformation: retrospective study and review of the literature. Ultrasound Obstet Gynecol (2012) 0.95
Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1. AIDS Res Hum Retroviruses (2001) 0.94
High variability of the gag/pol transframe region among HIV-1 isolates. C R Acad Sci III (1994) 0.94
Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. J Gen Virol (1996) 0.93
Conversion of thymidylate synthase into an HIV protease substrate. J Biol Chem (1996) 0.93
Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient. Proc Natl Acad Sci U S A (1990) 0.93
Sequence and analysis of chromosome I of the amitochondriate intracellular parasite Encephalitozoon cuniculi (Microspora). Genome Res (2001) 0.93
Genomic exploration of the hemiascomycetous yeasts: 2. Data generation and processing. FEBS Lett (2000) 0.92
Phylogenetic analyses of the ATP-binding constituents of bacterial extracytoplasmic receptor-dependent ABC-type nutrient uptake permeases. Res Microbiol (1995) 0.92
Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J Virol (1998) 0.92
Prenatal management of congenital cystic adenomatoid malformation of the lung. J Pediatr Surg (1993) 0.92
Prenatal diagnosis and postnatal follow-up of pericallosal lipoma: report of seven new cases. AJNR Am J Neuroradiol (2001) 0.91
Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge. AIDS Res Hum Retroviruses (1995) 0.90
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (1995) 0.90
Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur J Immunol (1999) 0.90
Diversity of the V3 region of HIV in Paris, France. AIDS (1993) 0.89
Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats. Vet Microbiol (1995) 0.89